Cormorant Asset Management, LP Bridge Bio Pharma, Inc. Transaction History
Cormorant Asset Management, LP
- $992 Million
- Q2 2025
A detailed history of Cormorant Asset Management, LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 1,600,000 shares of BBIO stock, worth $101 Million. This represents 6.97% of its overall portfolio holdings.
Number of Shares
1,600,000
Previous 2,000,000
20.0%
Holding current value
$101 Million
Previous $69.1 Million
0.08%
% of portfolio
6.97%
Previous 7.33%
Shares
22 transactions
Others Institutions Holding BBIO
# of Institutions
412Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.18 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.04 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$840 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$789 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$588 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.39B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...